Provention Bio

Quote




anonymous said:
Place is joke. Why anyone in sales and sales leadership continues the charade of “disease state education” is mystery
Click to expand...

what are they supposed to sell… there’s no approved drug. Disease state education and promoting the importance of testing is what they need to be doing before launch. Patients identified through testing will be the same patients receiving tep once it’s approved. Right?
 




anonymous said:
what are they supposed to sell… there’s no approved drug. Disease state education and promoting the importance of testing is what they need to be doing before launch. Patients identified through testing will be the same patients receiving tep once it’s approved. Right?
Click to expand...
I worked under JH at another company. Do all the CP bullshut you want, he’s a money maker. I will work for him again in a NY second…made more money under JH then anytime in my career. My money says he’s a repeat performer and anyone on this team will be handsomely rewarded. Wish there was an opening where I live. Sign Me Up!
 








The therapy is a 20 year old molecule that hasn’t met an efficacy endpoint in any sponsored trial. The only positive I could find was a non industry supported trial with a small number of patients. That coupled with what appears to be high attrition in under a year is reason to ask questions. Have a look at JH’s resume…the guy never stays in one place very long so this stop may be no different.
 




anonymous said:
The therapy is a 20 year old molecule that hasn’t met an efficacy endpoint in any sponsored trial. The only positive I could find was a non industry supported trial with a small number of patients. That coupled with what appears to be high attrition in under a year is reason to ask questions. Have a look at JH’s resume…the guy never stays in one place very long so this stop may be no different.
Click to expand...
If He Does, and so will you, swimming in coin!
 








Hi. Heard through the grapevine that there will be a few sales positions open coming up. Can anyone give me some insight into the company? Pay ranges? Car? Benefits?

thank you.
 




























So let’s review the timeline
Hire and train 3 months
FDA delay 4 months
Launch 3 months
ReLaunch 3 months
Downsize 3 Months
Get 4 month severance after being laid off

oh yeah only pay bonus in the 4 territories with reimbursement
 




Taking a big risk here. Company may be paying reps fairly well but will expect patients to pay for autoantibody testing out of pocket which very few patients are willing to do. If patients won’t pay or agree to test for antibodies then they sure as hell won’t be willing to sit for 12-14 daily infusions. There will certainly be some exceptions to this, but go ask any endocrinologist and they’ll tell you the same.
 




anonymous said:
Taking a big risk here. Company may be paying reps fairly well but will expect patients to pay for autoantibody testing out of pocket which very few patients are willing to do. If patients won’t pay or agree to test for antibodies then they sure as hell won’t be willing to sit for 12-14 daily infusions. There will certainly be some exceptions to this, but go ask any endocrinologist and they’ll tell you the same.
Click to expand...
If My Child had Diabetes Myllitis…I would scrub floors to pay for testing. I’m not applying to work here but can tell you I worked under JH and This person turned around a failing company in another disease state and I made more money working under his management than ever before. No Risk, No Reward. To the other posters with negative comments…Look Him Up. Jason Hoitt. Best Wishes, I am a shareholder.
 




anonymous said:
Taking a big risk here. Company may be paying reps fairly well but will expect patients to pay for autoantibody testing out of pocket which very few patients are willing to do. If patients won’t pay or agree to test for antibodies then they sure as hell won’t be willing to sit for 12-14 daily infusions. There will certainly be some exceptions to this, but go ask any endocrinologist and they’ll tell you the same.
Click to expand...

It is a big risk, only $113M in cash and marketable securities at end of Q1, not much of a stash to build the commercial organization and promote the drug. There is an "ATM" agreement for up to $150M, but dilution likely to be substantial. On the plus side this is an interesting drug, in a high unmet need market that has been largely ignored, but it would have been infinitely better to start with recently diagnosed and go backwards into "at risk" vs. trying to start in the "at risk" population.
 




anonymous said:
If My Child had Diabetes Myllitis…I would scrub floors to pay for testing. I’m not applying to work here but can tell you I worked under JH and This person turned around a failing company in another disease state and I made more money working under his management than ever before. No Risk, No Reward. To the other posters with negative comments…Look Him Up. Jason Hoitt. Best Wishes, I am a shareholder.
Click to expand...

Myllitis? You sound like a dumb ass so would be perfect for this company.
 








Similar threads

Iveric Bio
Replies
280
Views
63K
Biotech Startups
anonymous
Sesen Bio
Replies
0
Views
1K
Biotech Startups
anonymous
BlueBird Bio - Finished
Replies
13
Views
11K
Biotech Startups
anonymous
BAUDAX BIO
Replies
554
Views
113K
Biotech Startups
anonymous
Top Bottom
Back
Quote